- Home
- PODD vs CLS Comparison
PODD vs CLS Comparison
Compare PODD & CLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- CLS
- Stock Information
- Founded
- PODD 2000
- CLS 1994
- Country
- PODD United States
- CLS Canada
- Employees
- PODD N/A
- CLS N/A
- Industry
- PODD Medical/Dental Instruments
- CLS Electrical Products
- Sector
- PODD Health Care
- CLS Technology
- Exchange
- PODD Nasdaq
- CLS Nasdaq
- Market Cap
- PODD 23.8B
- CLS 28.1B
- IPO Year
- PODD 2007
- CLS 1998
- Fundamental
- Price
- PODD $317.83
- CLS $253.34
- Analyst Decision
- PODD Strong Buy
- CLS Buy
- Analyst Count
- PODD 18
- CLS 10
- Target Price
- PODD $337.06
- CLS $203.80
- AVG Volume (30 Days)
- PODD 662.8K
- CLS 2.7M
- Earning Date
- PODD 11-06-2025
- CLS 10-27-2025
- Dividend Yield
- PODD N/A
- CLS N/A
- EPS Growth
- PODD N/A
- CLS 55.91
- EPS
- PODD 3.32
- CLS 4.59
- Revenue
- PODD $2,359,500,000.00
- CLS $10,587,200,000.00
- Revenue This Year
- PODD $29.13
- CLS $20.66
- Revenue Next Year
- PODD $18.13
- CLS $17.22
- P/E Ratio
- PODD $94.90
- CLS $55.55
- Revenue Growth
- PODD 26.00
- CLS 20.52
- 52 Week Low
- PODD $225.37
- CLS $54.52
- 52 Week High
- PODD $353.50
- CLS $261.83
- Technical
- Relative Strength Index (RSI)
- PODD 40.26
- CLS 53.29
- Support Level
- PODD $306.03
- CLS $230.24
- Resistance Level
- PODD $315.44
- CLS $257.58
- Average True Range (ATR)
- PODD 8.58
- CLS 11.85
- MACD
- PODD -1.93
- CLS -3.33
- Stochastic Oscillator
- PODD 45.94
- CLS 39.76
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
About CLS Celestica Inc.
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.